First Implantable Continuous Glucose Monitor Receives FDA Approval for Type 1 and Type 2 Diabetes
The Eversense Continuous Glucose Monitoring System can be used for 90 days with the same sensor. It’s the first fully implantable device approved by the Food and Drug Administration.

https://www.everydayhealth.com/type-2-diabete...diabetics/